Search Results - "Cannon, Michael W"

Liquid Biopsy-based Precision Therapy in Patients with Advanced Solid Tumors: A Real-world Experience from a Community-based Oncology Practice by Choucair, Khalil, Mattar, Bassam Ibrahim, Van Truong, Quoc, Koeneke, Travis, Van Truong, Phu, Dakhil, Christopher, Cannon, Michael W, Page, Seth Joel, Deutsch, Jeremy Michael, Carlson, Eric, Moore, Dennis Frederic, Nabbout, Nassim H, Kallail, K James, Dakhil, Shaker R, Reddy, Pavan S

“…Liquid biopsy testing offers a significant potential in selecting signal-matched therapies for advanced solid malignancies. The feasibility of liquid biopsy…”
Get full text

Epratuzumab with rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy in patients with previously untreated diffuse large B-cell lymphoma by Micallef, Ivana N.M., Maurer, Matthew J., Wiseman, Gregory A., Nikcevich, Daniel A., Kurtin, Paul J., Cannon, Michael W., Perez, Domingo G., Soori, Gamini S., Link, Brian K., Habermann, Thomas M., Witzig, Thomas E.

“…Approximately 60% of patients with diffuse large B-cell non-Hodgkin lymphoma (DLBCL) are curable with rituximab plus cyclophosphamide, doxorubicin,…”
Get full text

Clinical Utility of Genomic Recurrence Risk Stratification in Early, Hormone-Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer: Real-World Experience by Choucair, Khalil, Page, Seth J., Mattar, Bassam I., Dakhil, Christopher S., Nabbout, Nassim H., Deutsch, Jeremy M., Truong, Quoc V., Truong, Phu V., Moore, Dennis F., Cannon, Michael W., Kallail, K. James, Moore, Joseph A., Dakhil, Shaker R., Diab, Radwan, Kamran, Syed, Reddy, Pavan S.

“…RNA-based genomic risk assessment estimates chemotherapy benefit in patients with hormone-receptor positive (HR+)/Human Epidermal Growth Factor 2-negative…”
Get full text

Exploring Therapeutic Decisions in Elderly Patients with Non-Small Cell Lung Cancer: Results and Conclusions from North Central Cancer Treatment Group Study N0222 by Kean, Heidi Mc, Stella, Philip J., Hillman, Shauna L., Rowland, Kendrith M., Cannon, Michael W., Behrens, Robert J., Gross, Gerald G., Sborov, Mark D., Friedman, Eliot L., Jatoi, Aminah

“…How do oncologists choose therapy for the elderly? Oncologists assigned patients aged 65 years or older with incurable non-small cell lung cancer to: (a)…”
Get full text

Phase II study of gemcitabine plus cisplatin in patients with metastatic breast cancer: a North Central Cancer Treatment Group Trial by Burch, Patrick A, Mailliard, James A, Hillman, David W, Perez, Edith A, Krook, James E, Rowland, Kendrith M, Veeder, Michael H, Cannon, Michael W, Ingle, James N

“…This 2-stage, phase II cooperative group trial examined the efficacy and toxicity of 1000 mg/m2 gemcitabine plus 25 mg/m2 cisplatin weekly for 3 weeks and…”
Get full text

Weekly carboplatin and paclitaxel in elderly non-small-cell lung cancer patients (≥65 years of age): A phase II North Central Cancer Treatment Group Study by JATOI, Aminah, STELLA, Philip J, HILLMAN, Shauna, MAILLIARD, James A, VANONE, Stephanie, PEREZ, Edith A, CANNON, Michael W, GEYER, Susan, WIESENFELD, Martin, JETT, James R

“…The purpose of this study was to determine the tumor response rate and toxicity profile of low-dose weekly carboplatin and paclitaxel in advanced…”
Get full text

Daily activities: exploring their spectrum and prognostic impact in older, chemotherapy-treated lung cancer patients by JATOI, Aminah, HILLMAN, Shauna, STELLA, Philip J, MAILLIARD, James A, SLOAN, Jeff, VANONE, Stephanie, CANNON, Michael W, KUTTEH, Leila, KANARD, Anne, JETT, James R

“…Performance scores predict benefits and toxicities from chemotherapy. Among older cancer patients, however, many investigators have empirically called for a…”
Get full text

Concepts and Themes: A Learning Odyssey by Cannon, Michael W.

“…Learning can be much like Odysseus' journey to Ithaka as described by Cavafy in his 1992 prose, Ithaka, full of spectacular adventures, enchantment, and the…”
Get full text

Clinical utility of genomic recurrence risk stratification in early, hormone receptor–positive, human epidermal growth factor receptor 2–negative breast cancer by Choucair, Khalil, Page, Seth Joel, Mattar, Bassam Ibrahim, Dakhil, Christopher, Nabbout, Nassim H., Deutsch, Jeremy Michael, Truong, Quoc Van, Truong, Phu Van, Moore, Dennis Frederic, Cannon, Michael W., Kallail, K. James, Moore, Joseph A, Dakhil, Shaker R., Diab, Radwan, Kamran, Syed, Reddy, Pavan S.

“…546 Background: RNA-based genomic assessment of recurrence risk is used to estimate chemotherapy benefit in patients with hormone-receptor positive (HR+)/Human…”
Get full text

Liquid biopsy testing: Impact on treatment assignment and survival in a community-based oncology practice—A real-world experience by Choucair, Khalil, Mattar, Bassam Ibrahim, Truong, Quoc Van, Koeneke, Travis Lee, Truong, Phu Van, Dakhil, Christopher, Cannon, Michael W., Page, Seth Joel, Deutsch, Jeremy Michael, Carlson, Eric A., Moore, Dennis Frederic, Nabbout, Nassim H., Kallail, K. James, Dakhil, Shaker R., Reddy, Pavan S.

“…Abstract only 3027 Background: Liquid biopsy is a promising, rapid and minimally invasive genetic test examining circulating tumor DNA. It offers a significant…”
Get full text

Liquid biopsy: A community-based oncology practice experience by Choucair, Khalil, Mattar, Bassam Ibrahim, Truong, Quoc Van, Koeneke, Travis Lee, Truong, Phu Van, Dakhil, Christopher, Cannon, Michael W., Page, Seth Joel, Deutsch, Jeremy Michael, Carlson, Eric A., Moore, Dennis Frederic, Nabbout, Nassim H., Kallail, K. James, Dakhil, Shaker R., Reddy, Pavan S.

“…Abstract only 3527 Background: Liquid biopsy is a promising and minimally invasive genetic test examining plasma circulating tumor DNA. Coupled with the…”
Get full text

A retrospective analysis comparing efficacy of filgastrim-sndz versus filgastrim for autologous, peripheral stem cell mobilization in patients with multiple myeloma and lymphoma by Young, Derek, Reddy, Pavan S., Mattar, Bassam Ibrahim, Truong, Phu Van, Page, Seth Joel, Truong, Quoc Van, Nabbout, Nassim H., Dakhil, Chris, Cannon, Michael W., Dakhil, Shaker R., Deutsch, Jeremy Michael, Bluml, Patricia

“…Abstract only…”
Get full text

The application of next-generation sequencing in the community clinical oncology setting by Reddy, Pavan S., Rahal, Ahmad Khalil, Kallail, K. James, Moore, Dennis Frederic, Truong, Phu Van, Mattar, Bassam Ibrahim, Cannon, Michael W., Nabbout, Nassim H., Page, Seth Joel, Truong, Quoc Van, Dakhil, Christopher, Deutsch, Jeremy Michael, Dakhil, Shaker R.

“…Abstract only…”
Get full text

A prospective randomized phase III trial comparing consolidation therapy with or without strontium-89 following induction chemotherapy in androgen-independent prostate cancer by Wang, Jennifer, Tu, Shi-Ming, Pagliaro, Lance C., Weiss, Matthias, Hajdenberg, Julio, Tseng, Jennifer, Wade, James Lloyd, Belt, Robert J., Cannon, Michael W., Fisch, Michael

“…Abstract only 90 Background: New therapies have shown benefit for advanced prostate cancer, but are not curative. Bone metastases cause significant prostate…”
Get full text

PET Scan Results of NCCTG N0489: Epratuzumab and Rituximab in Combination with Cyclophosphamide, Doxorubicin, Vincristine and Prednisone Chemotherapy (ER-CHOP) in Patients with Previously Untreated Diffuse Large B-Cell Lymphoma by Micallef, Ivana N., Maurer, Matthew J., Witzig, Thomas E., Nikcevich, Daniel, Kurtin, Paul, Cannon, Michael W., Flynn, Patrick J., Soori, Gamini S., Lowe, Val, Wiseman, Gregory

“…Abstract 137 FDG-PET/CT after 2–4 cycles of chemotherapy has been shown to be predictive of outcome in patients with aggressive lymphoma. This multicenter…”
Get full text

Multiple myeloma in a 25-year-old woman by Badwey, T M, Murphy, D A, Eyster, R L, Cannon, M W

“…A 25-year-old woman with acute knee pain and a lytic area in the proximal femur was diagnosed as having multiple myeloma (MM). This case is one of only eight…”
Get more information

The battalion medical platoon: a flawed scalpel by Cannon, M W, Stoute, J A

“…This article discusses the current organization and doctrine for a medical platoon in an armour-heavy task force in light of experience gained in Operations…”
Get more information